Ghrelin and insulin gene expression changes in streptozotocin-induced diabetic rats after rosiglitazone pretreatment

European Journal of Histochemistry

Volumn 51, Issue 1, 2007, Pages 11-18

  Yildirim, S ^a   Sundler, F ^b   Bolkent, Sema ^a,c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b LUND UNIVERSITY   (Sweden)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ghrelin; Immunohistochemistry; in situ hybridization; Rosiglitazone

Indexed keywords

GHRELIN; INSULIN; MESSENGER RNA; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; PEPTIDE HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; ANIMAL; BIOSYNTHESIS; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENCE IN SITU HYBRIDIZATION; METABOLISM; PANCREAS ISLET BETA CELL; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INSULIN; INSULIN-SECRETING CELLS; MALE; PEPTIDE HORMONES; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 34250828436     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adeghate E, Ponery AS. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 2002; 14: 555-60.
2. Abiko Y, Suzuki H, Masaoka T, Nomura S, Kurabayashi K, Hosoda H, et al. Enhanced plasma ghrelin levels in Helicobacter pylori-colonized, interleukin-1-receptor type 1-homozygous knockout (IL-1 R1-/-) mice. World J Gastroenterol 2005; 11: 4148-53.
3. Araki E, Lipes MA, Patti ME, Bruning JC, Haag III B, Johnson RS, et al. Alternative pathway of insulin signalling in mice with targeted distruption of the IRS-1 gene. Nature 1994; 372: 186-90.
4. Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, et al. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells. Biochem Biophys Res Commun 2003; 304: 378-84.
5. Bolkent S, Yanardag R, Bolkent S, Mutlu O, Yildirim S, Kangawa K, et al. The effect of zinc supplementation on ghrelin-immunoreactive cells and lipid parameters in gastrointestinal tissue of streptozotocin-induced female diabetic rats. Mol Cell Biochem 2006; 286: 77-85.
6. Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, Aye T, et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes 2004; 2: 6-22.
7. Brand CL, Sturis J, Gotfredsen CF, Fleckner J, Fledelius C, Hansen BF, et al. Dual PPARα/γ activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats. Am J Physiol Endocrinol Metab 2002; 284: 841-54.
8. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001; 86: 5083-6.
9. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-9.
10. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NSA, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation. Eur J Pharmacol 2004; 483: 79-93.
11. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. Ghrelin is present in pancreatic alpha cells of human and rats and stimulates insulin secretion. Diabetes 2002; 51: 124-9.
12. ++ signalling in beta cells. Diabetes 2004; 53: 3142-51.
13. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002; 146: 241-4.
14. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, et al. β cell mass dynamics in Zucker diabetic fatty rats: Rosiglitazone prevents the rise in net cell death. Diabetes 2001; 50: 1021-9.
15. Fukuhara S, Suzuki H, Masaoka T, Arakawa M, Hosoda H, Minegishi Y, et al. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. Am J Physiol Gastrointest Liver Physiol 2005; 289: G138-45.
16. Ishida H, Takizawa M, Ozawa S, Nakamichi Y, Yamaguchi S, Katsuta H, et al. Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: Possible protection of β cells from oxidative stress. Metabolism 2004; 53: 488-94.
17. Kageyama H, Funahashi H, Hirayama M, Takenoya F, Kita T, Kato S, et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005; 126: 67-71.
18. Koh EH, Kim M-S, Park J-Y, Kim HS, Youn J-Y, Park H-S, et al. Peroxisome proliferator-activated receptor (PPAR)-α activation prevents diabetes in OLETF rats. Diabetes 2003; 52: 2331-7.
19. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
20. Lupi R, Guerra SD, Marselli L, Bugliani M, Boggi U, Mosca F, et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: 560-67.
21. Masaoka T, Suzuki H, Hosoda H, Ota T, Minegishi Y, Nagata H, et al. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. Febs Lett 2003; 541: 64-8.
22. Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, et al. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication. Hepatogastroenterol 2005; 52: 1-4.
23. Mori M, Suzuki H, Masaoka T, Imaeda H, Nomoto Y, Hosoda H, et al. Intravenous ghrelin administration enhances gastric acid secretion - evaluation using wireless pH capsule. Aliment Pharm Ther Symp Ser 2006; 2: 96-103.
24. Mulder H, Lindh AC, Sundler F. Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat. A combined in situ hybridization and immunocytochemical study. Cell Tissue Res 1993; 274: 467-74.
25. Nishizawa T, Suzuki H, Nomoto Y, Masaoka T, Hosoda H, Mori M, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharm Ther Symp Ser 2006; 2: 104-10.
26. Ogawa J, Takahashi S, Fujiwara T, Fukushige J, Hosokawa T, Izumi T, et al. Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice. Life Sci 1999; 65: 1287-96.
27. Prado CL, Pugh-Bernard A, Elghazi L, Sosa-Pineda B, Sussel L. Ghrelin cells replace insulin-producing beta cells in two models of pancreas development. Proc Natl Acad Sci USA 2004; 101: 2924-9.
28. Reimer MK, Pacini G, Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003; 144: 916-21.
29. Richardson H, Campbell SC, Smith SA, Macfarlane WM. Effects of rosiglitazone and metformin on pancreatic beta cell gene expression. Diabetologia 2006; 49: 685-96.
30. Shibata T, Takeuchi S, Yokota S, Kakimoto K, Yonemori F, Wakitani K. Effects of peroxisome proliferator-activated receptor-α and -γ agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br J Pharmacol 2000; 130: 495-504.
31. Skak K, Gotfredsen CF, Lundsgaard D, Hansen JB, Sturis J, Markholst H. Improved beta cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta cell selective KATP channel opener. Diabetes 2004; 53: 1089-95.
32. Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio - a possible novel and noninvasive marker for gastric atrophy. Hepatogastroenterol 2004a; 51: 1249-54.
33. Suzuki H, Masaoka T, Hosoda H, Ota T, Minegishi Y, Nomura S, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 2004b; 53: 187-94.
34. Suzuki H, Masaoka T, Nomoto Y, Hosoda H, Mori M, Nishizawa T, et al. Increased levels of plasma ghrelin in peptic ulcer disease. Aliment Pharm Ther Symp Ser 2006; 2: 120-6.
35. Takamura T, Ando H, Nagai Y, Yamashita H, Nohara E, Kobayashi K. Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. Diabetes Res Clin Pract 1999; 44: 107-14.
36. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002; 87: 1300-8.
37. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-9.
38. Wierup N, Yang S, McEvilly RJ, Mulder H, Sundler F. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 2004; 52: 301-10.
39. Yang C, Chang TJ, Chang JC, Liu MW, Tai TY, Hsu WH, et al. Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. Diabetes 2001; 50: 2598-602.
40. Yue T, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 2001; 104: 2588-94.